The idea that patients could get better responses with shorter courses of therapy runs counter to the current standard of care in melanoma.
2024
World-first vaccine for melanoma cuts risk of death in half, trial finds
A world-first personalised vaccine for melanoma vaccine has been found to reduce the risk of cancer reoccurrence or death by 49 per cent over three years.
The ‘cancer treatment revolution’ targetting melanoma
In Australia one person is diagnosed with the deadly skin cancer, melanoma, every 30 minutes. But there is hope.
Side Effects of Mektovi: What You Need to Know
Mektovi (binimetinib) is a prescription drug that’s used to treat certain types of cancer. Mektovi can cause side effects that range from mild to serious. Examples include nausea, diarrhea, and vomiting.